Pathway Genomics Corporation, a San Diego-based CAP-accredited clinical laboratory that offers genetic testing services worldwide, today announced it has received a Clinical Laboratory Permit from the New York State Department of Health. The permit allows authorized health care providers in the state of New York the ability to offer their patients Pathway Fit®, the company’s diet, metabolism, and exercise genetic test.

Considered one of the most rigorous control standards in the country, the validation process required for a New York State Clinical Laboratory Permit is designed to ensure reliable, accurate clinical laboratory services. “Obtaining a New York State Clinical Laboratory Permit is an exciting benchmark in Pathway’s growth and a testament to the quality, reliability and accuracy of Pathway’s services,” said David Becker, Ph.D., Pathway Genomics’ chief scientific officer.


“Obtaining a New York State Clinical Laboratory Permit is an exciting benchmark in Pathway’s growth and a testament to the quality, reliability and accuracy of Pathway’s services,” said David Becker, Ph.D., Pathway Genomics’ chief scientific officer.

Pathway Fit analyzes genes associated with food metabolism and exercise response, and it provides actionable recommendations that aim to help people maintain a healthy weight – and lose unhealthy weight – by tailoring their diet and exercise plans to their genetics.

The only test of its kind available in New York, Pathway Fit provides physicians and patients with a critical new tool to help combat rising obesity rates. According to the CDC, 60 percent of New York’s adults 18 years old and over are overweight, and approximately 24 percent are obese. Additionally, the New York State Department of Health reports that one-third of school-age children in New York State – not including New York City – are overweight or obese.


“Bringing Pathway Fit to the physicians and residents of the state of New York is a vital objective in our mission to serve a broader patient base,” said Michael Nova, M.D., Pathway Genomics’ chief medical officer. “We feel that Pathway Fit will be a major and necessary catalyst for behavioral change in the lives of many people living in New York.”

“Bringing Pathway Fit to the physicians and residents of the state of New York is a vital objective in our mission to serve a broader patient base,” said Michael Nova, M.D., Pathway Genomics’ chief medical officer. “We feel that Pathway Fit will be a major and necessary catalyst for behavioral change in the lives of many people living in New York.”

Comments are closed.